(Q36289382)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Immunohistochemical expression of platelet-derived growth factor receptors in ovarian cancer patients with long-term follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1 reference

Karina Dahl Steffensen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Christine Vestergaard Madsen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Marianne Waldstrøm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Anders Jakobsen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

23 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

Pathology Research International

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

851432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 3.0 Unported

16 February 2020

copyright license

start time

23 September 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

A phase 3 trial of bevacizumab in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Overview of anti-angiogenic agents in development for ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

PDGF and vessel maturation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Role of platelet-derived growth factors in physiology and medicine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

First-line randomized trials: revisiting the Ptolemaic universe

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Pericytes: gatekeepers in tumour cell metastasis?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Angiogenesis as a therapeutic target

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

VEGF-null cells require PDGFR alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

The PDGF family: four gene products form five dimeric isoforms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Chemotherapy for advanced ovarian cancer: overview of randomized trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Mechanism of action and in vivo role of platelet-derived growth factor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Signal transduction via platelet-derived growth factor receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

The Measurement of Observer Agreement for Categorical Data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Expression of protein tyrosine kinases in head and neck squamous cell carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Incorporation of bevacizumab in the primary treatment of ovarian cancer

29 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F851432

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F851432

Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F851432

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F851432

Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F851432

Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F851432

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F851432

Co-expression of receptor tyrosine kinases in esophageal adenocarcinoma and squamous cell cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3461633

Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms

22 September 2018

1 reference

12 December 2020

Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas

1 reference

12 December 2020

Expression of platelet-derived growth factors and their receptors in ovarian clear-cell carcinoma and its putative precursors

1 reference

12 December 2020

Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells

1 reference

12 December 2020

The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/851432

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

23094199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23094199%20AND%20SRC:MED&resulttype=core&format=json